Biosimulation Market Is Expected to Reach $4.9 billion by 2030, Grow at a CAGR Of 20.1% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd. Farmington, May 10, 2023 (GLOBE NEWSWIRE) -- The Global Biosimulation Market Was Valued At $1.3 billion In 2022 And Is Expected To Expand  $4.9 billion By 2030 at a CAGR Of 20.1% From 2022 To 2030....

Biosimulation Market Size to reach 3.08 Billion in 2022, Growing at a CAGR of 21.56% Over the Forecast Period 2023 to 2032: Quince Market Insights Pune, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The global Biosimulation Market reach USD 3.08 Billion in 2022 and is expected to exhibit a CAGR of 21.56% over the forecast period 2023 to 2032, according to...

Biosimulation Market Size Worth USD 10.3 billion, Globally by 2031 with a massive CAGR of 15.5%, Growth Plus Reports Pune, June 22, 2022 (GLOBE NEWSWIRE) -- The Global Biosimulation Market is expected to clock US$ ~10.3 billion by 2031 owing to the increasing demand for biosimulation for drug discovery and drug...

Biosimulation Market Size to Worth Around US$ 9.17 Bn by 2030 Ottawa, April 27, 2022 (GLOBE NEWSWIRE) -- The drug resistance characteristics of certain diseases like bacterial infections and cancer have resulted in the increased incidences of drug relapse. The...

Global Biosimulation Market Will Reach USD 4.58 Billion By 2025: Zion Market Research New York, NY, April 02, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biosimulation Market by Product (Software and Services), by Application (Drug Development,...